203 related articles for article (PubMed ID: 14657950)
21. Lymphatic vessel density as prognostic marker in esophageal adenocarcinoma.
Saad RS; Lindner JL; Liu Y; Silverman JF
Am J Clin Pathol; 2009 Jan; 131(1):92-8. PubMed ID: 19095571
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical expression of vascular endothelial growth factor (VEGF) does not correlate with microvessel density in renal cell carcinoma.
Raica M; Cimpean AM; Anghel A
Neoplasma; 2007; 54(4):278-84. PubMed ID: 17822316
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical evaluation of the microvascular density through the expression of TGF-beta (CD 105/endoglin) and CD 34 receptors and expression of the vascular endothelial growth factor (VEGF) in oligodendrogliomas.
Netto GC; Bleil CB; Hilbig A; Coutinho LM
Neuropathology; 2008 Feb; 28(1):17-23. PubMed ID: 18181830
[TBL] [Abstract][Full Text] [Related]
24. Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma.
Yang LY; Lu WQ; Huang GW; Wang W
BMC Cancer; 2006 May; 6():110. PubMed ID: 16650286
[TBL] [Abstract][Full Text] [Related]
25. Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas.
Barresi V; Cerasoli S; Vitarelli E; Tuccari G
Acta Neuropathol; 2007 Aug; 114(2):147-56. PubMed ID: 17594108
[TBL] [Abstract][Full Text] [Related]
26. Expression of endoglin (CD105) in cervical cancer.
Zijlmans HJ; Fleuren GJ; Hazelbag S; Sier CF; Dreef EJ; Kenter GG; Gorter A
Br J Cancer; 2009 May; 100(10):1617-26. PubMed ID: 19352388
[TBL] [Abstract][Full Text] [Related]
27. mRNA expression of the angiogenesis markers VEGF and CD105 (endoglin) in human breast cancer.
Gómez-Esquer F; Agudo D; Martínez-Arribas F; Nuñez-Villar MJ; Schneider J
Anticancer Res; 2004; 24(3a):1581-5. PubMed ID: 15274325
[TBL] [Abstract][Full Text] [Related]
28. Significance of CD 105 expression for tumour angiogenesis and prognosis in endometrial carcinomas.
Salvesen HB; Gulluoglu MG; Stefansson I; Akslen LA
APMIS; 2003 Nov; 111(11):1011-8. PubMed ID: 14629267
[TBL] [Abstract][Full Text] [Related]
29. Prediction of metastasis risk (11 year follow-up) using VEGF-R1, VEGF-R2, Tie-2/Tek and CD105 expression in breast cancer (n=905).
Dales JP; Garcia S; Carpentier S; Andrac L; Ramuz O; Lavaut MN; Allasia C; Bonnier P; Taranger-Charpin C
Br J Cancer; 2004 Mar; 90(6):1216-21. PubMed ID: 15026804
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of Endoglin (CD105) expression in pediatric rhabdomyosarcoma.
Di Paolo V; Russo I; Boldrini R; Ravà L; Pezzullo M; Benedetti MC; Galardi A; Colletti M; Rota R; Orlando D; Crocoli A; Peinado H; Milano GM; Di Giannatale A
BMC Cancer; 2018 Jan; 18(1):31. PubMed ID: 29304781
[TBL] [Abstract][Full Text] [Related]
31. Estimation of angiogenesis with anti-CD105 immunostaining in the process of colorectal cancer development.
Akagi K; Ikeda Y; Sumiyoshi Y; Kimura Y; Kinoshita J; Miyazaki M; Abe T
Surgery; 2002 Jan; 131(1 Suppl):S109-13. PubMed ID: 11821796
[TBL] [Abstract][Full Text] [Related]
32. The differences between the endothelial area marked with CD31 and CD105 in colorectal carcinomas by computer-assisted morphometrical analysis.
Jung I; Gurzu S; Raica M; Cîmpean AM; Szentirmay Z
Rom J Morphol Embryol; 2009; 50(2):239-43. PubMed ID: 19434317
[TBL] [Abstract][Full Text] [Related]
33. Microvessel Landscape Assessment in Pancreatic Ductal Adenocarcinoma: Unclear Value of Targeting Endoglin (CD105) as Prognostic Factor of Clinical Outcome.
Lytras D; Leontara V; Kefala M; Foukas PG; Giannakou N; Pouliakis A; Dervenis C; Panayiotides IG; Karakitsos P
Pancreas; 2015 Jan; 44(1):87-92. PubMed ID: 25058886
[TBL] [Abstract][Full Text] [Related]
34. Angiogenic factors in squamous cell carcinoma of the oral cavity: do they have prognostic relevance?
Schimming R; Reusch P; Kuschnierz J; Schmelzeisen R
J Craniomaxillofac Surg; 2004 Jun; 32(3):176-81. PubMed ID: 15113577
[TBL] [Abstract][Full Text] [Related]
35. Analysis of neovasculature in uveal melanoma by targeting the TGFbeta-binding receptor endoglin: is there prognostic relevance of proliferating endothelium?
Ziemssen F; Wegner R; Wegner J; Tatar O; Süsskind D; Gelisken F; Rohrbach M; Bartz-Schmidt KU; Grisanti S
Graefes Arch Clin Exp Ophthalmol; 2006 Sep; 244(9):1124-31. PubMed ID: 16523306
[TBL] [Abstract][Full Text] [Related]
36. Pathological significance and prognostic role of microvessel density, evaluated using CD31, CD34, and CD105 in prostate cancer patients after radical prostatectomy with neoadjuvant therapy.
Miyata Y; Mitsunari K; Asai A; Takehara K; Mochizuki Y; Sakai H
Prostate; 2015 Jan; 75(1):84-91. PubMed ID: 25307287
[TBL] [Abstract][Full Text] [Related]
37. Long-term prognostic significance of neoangiogenesis in breast carcinomas: comparison of Tie-2/Tek, CD105, and CD31 immunocytochemical expression.
Dales JP; Garcia S; Carpentier S; Andrac L; Ramuz O; Lavaut MN; Allasia C; Bonnier P; Charpin C
Hum Pathol; 2004 Feb; 35(2):176-83. PubMed ID: 14991534
[TBL] [Abstract][Full Text] [Related]
38. Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study.
Rubatt JM; Darcy KM; Hutson A; Bean SM; Havrilesky LJ; Grace LA; Berchuck A; Secord AA
Gynecol Oncol; 2009 Mar; 112(3):469-74. PubMed ID: 19135712
[TBL] [Abstract][Full Text] [Related]
39. Microvessel density assessment in benign and malignant endometrial changes.
Czekierdowski A; Czekierdowska S; Czuba B; Cnota W; Sodowski K; Kotarski J; Zwirska-Korczala K
J Physiol Pharmacol; 2008 Sep; 59 Suppl 4():45-51. PubMed ID: 18955753
[TBL] [Abstract][Full Text] [Related]
40. Vascular endothelial growth factor and endoglin expression in colorectal cancer.
Dassoulas K; Gazouli M; Theodoropoulos G; Christoni Z; Rizos S; Zisi-Serbetzoglou A; Glava C; Karantanos T; Klonaris C; Karakitsos P
J Cancer Res Clin Oncol; 2010 May; 136(5):703-8. PubMed ID: 19890661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
